Page last updated: 2024-08-25

rosiglitazone and Hemorrhagic Shock

rosiglitazone has been researched along with Hemorrhagic Shock in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harn, HJ; Hsu, BG; Lee, CJ; Lee, RP; Peng, TC; Subeq, YM; Yang, FL	1

Other Studies

1 other study(ies) available for rosiglitazone and Hemorrhagic Shock

Article	Year
Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats. Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:10 Topics: Animals; Anti-Inflammatory Agents; Blood Chemical Analysis; Blood Pressure; Chemokine CCL2; Enzyme-Linked Immunosorbent Assay; Heart Rate; Interleukin-6; Multiple Organ Failure; Rats; Rats, Wistar; Rosiglitazone; Shock, Hemorrhagic; Survival Analysis; Thiazolidinediones; Tumor Necrosis Factor-alpha	2011

Article

Year

Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats.

Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:10

Topics: Animals; Anti-Inflammatory Agents; Blood Chemical Analysis; Blood Pressure; Chemokine CCL2; Enzyme-Linked Immunosorbent Assay; Heart Rate; Interleukin-6; Multiple Organ Failure; Rats; Rats, Wistar; Rosiglitazone; Shock, Hemorrhagic; Survival Analysis; Thiazolidinediones; Tumor Necrosis Factor-alpha

2011